✦ LIBER ✦

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

✍ Scribed by Eileen E. Ming; Michael H. Davidson; Sanjay K. Gandhi; Marcelo Marotti; Carolyn G. Miles; Xiongkan Ke; James M. McKenney

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Validation of Bone Metastases Coding in

✍ Hernandez, Rohini Khorana; Quach, David; Wade, Sally W.; Pirolli, Melissa; Reich 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Co-medication of statins and CYP3A4 inhi

✍ Helene M. Devold; Espen Molden; Svetlana Skurtveit; Kari Furu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

PCN94 PREDICTORS OF TREATMENT CHOICE IN

✍ S Kotapati; D Mitra; KL Davis; U Iloeje 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Distribution of left ventricle ejection

✍ Park, J.; Lin, J.; Tian, H.; Goodman, M.; McAdam-Marx, C.; Kahler, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Clinical importance of the drug interact

✍ Christopher G. Rowan; Steven M. Brunelli; Jeffrey Munson; James Flory; Peter P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Tecarfarin, a Novel Vitamin K Reductase

✍ Bavisotto, Linda M.; Ellis, David J.; Milner, Peter G.; Combs, Daniel L.; Irwin, 📂 Article 📅 2011 🏛 Sage Publications 🌐 English ⚖ 267 KB